Send me a link:

*Text messaging rates may apply.

 Dow Up 0.12% Nasdaq Down 0.08%

Omeros Corporation (OMER)

-NasdaqGM
13.75 Down 0.23(1.65%) 3:38PM EDT - Nasdaq Real Time Price
Prev Close:13.98
Open:14.00
Bid:13.71 x 200
Ask:13.77 x 200
1y Target Est:32.80
Beta:1.16
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:13.40 - 14.03
52wk Range:4.75 - 18.80
Volume:153,176
Avg Vol (3m):463,659
Market Cap:466.29M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OMERDown 1.65%466.29M
ACADDown 1.60%2.01B
ALKSDown 1.94%6.37B
APPA 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):783.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.58
Quarterly EPS Est (Jun-14) :-0.46
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes products targeting inflammation, coagulopathies, and disorders of the central nervous system. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback